ArticleCancer control : journal of the Moffitt Cancer Center
Partnering With Faith Communities to Increase Knowledge of Precision Medicine and Genetic Research in the Black Community.
Article in Cancer control : journal of the Moffitt Cancer Center. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Article
- Article
- Editorial: Co-Creating Community-Living Interventions for Sustainable Cancer Control Programs: Meeting the Community Where They Are to Address Cancer Burden.Cancer control : journal of the Moffitt Cancer CenterArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
IntroductionGenomic and genetic research are integral to precision medicine and contemporary cancer care. These approaches hold great promise for addressing longstanding racial cancer disparities and poor cancer outcomes observed in Black populations. However, in Black populations, there are several barriers to participating in genomic and genetic research. Faith-based organizations, specifically Black churches, offer a unique opportunity to both address these barriers and foster the environment for community engagement that can lead to greater awareness and interest in genomics, genetics, precision medicine, and cancer clinical trials.MethodsIn the present study, the study team partnered with metropolitan Detroit Black churches to develop and implement a pilot intervention to increase genetic and clinical trial literacy, as well as interest in cancer clinical trials, titled, "The Future of Medicine is Now". During the intervention, facilitators presented videos, produced by the project team and partners, that addressed precision medicine, familial risk, genetic risk assessment, and cancer clinical trials. Facilitators also responded to questions and led discussion throughout the program.ResultsIn total, 106 individuals consented to participate in research components of the program. The mean age of the participants was 46.5 (SD = 16.8) years; 73.6% (n = 48) identified as female, and 89.6% (n = 95) identified as Black. Attitudes related to clinical trials participation improved from pre- to post-education session; at pre-test 49.5% of participants agreed with the statement "I am likely to search for a clinical trial that I might be eligible for", as opposed to 67.0% at post-test. Improvements related to genetic literacy were also seen from pre- to post-test.ConclusionResults from this study suggest that collaborations with faith-based organizations are effective in building knowledge and interest in genomics, genetics, precision medicine, and research in Black communities. Future research should aim to incorporate community- and culturally-specific engagement strategies to increase participation in research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.